AEs and SAEs
| AE and SAE . | No. of patients, all grades . | No. of patients, grade ≥3 . |
|---|---|---|
| AEs | ||
| Infection | 1 | 1 |
| Gastrointestinal disorders | ||
| Esophagitis | 1 | 1 |
| Mucositis | 11 | 4 |
| Elevated transaminases | 1 | |
| Musculoskeletal disorders | 1 | |
| Nutritional disorders | 2 | |
| SAEs | ||
| Renal failure | 1 | |
| Infections requiring hospitalization | 2 | |
| Death | 10 | |
| AE and SAE . | No. of patients, all grades . | No. of patients, grade ≥3 . |
|---|---|---|
| AEs | ||
| Infection | 1 | 1 |
| Gastrointestinal disorders | ||
| Esophagitis | 1 | 1 |
| Mucositis | 11 | 4 |
| Elevated transaminases | 1 | |
| Musculoskeletal disorders | 1 | |
| Nutritional disorders | 2 | |
| SAEs | ||
| Renal failure | 1 | |
| Infections requiring hospitalization | 2 | |
| Death | 10 | |
Adverse events (AEs) and serious AEs (SAEs) directly related to IM-TMI fludarabine-melphalan conditioning are shown.